LIVE

OSCR

Oscar Health, Inc.

OSCR

NYSE·Healthcare·Medical - Healthcare Plans·Mkt cap $8.3B

$31.96

▲ +0.19%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$10.69 - $33.10

P/E

-96.85

Fwd P/E

53.07

Beta

2.39

Div Yield

0.00%

Avg Vol

7.6M

Shares Out

259.3M

Mkt Cap

$8.3B

Price action

Price chart

Up 91.9% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

5 reasons

  • Technology-first platform enabling superior member experience and operational efficiency
  • Data analytics capabilities for risk management and cost optimization
  • Direct-to-consumer digital engagement reducing distribution costs
  • Integrated +Oscar B2B platform creating ecosystem lock-in
  • Lean operational model compared to legacy insurance competitors
▼

Bear Case

2 risks

  • High volatility (beta 2.4). Larger-than-normal price swings expected.
  • High premium - requires strong execution

Growth

Turning profitable

Expansion into new geographic markets and plan offerings

Value

High premium - requires strong execution

Momentum

Hot

+167.6% over 3m

Quality

Thin

Excellent business quality

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: May 5, 2026

“
Q2 26 RECAP

MAY 6, 2026

Reported EPS of $2.07 vs $1.11 consensus (+86.5% surprise). Revenue of $4.6B vs $4.9B expected (-6.5%).

EPS beat +86.5%
Revenue miss

EPS surprise · last 4Q

1 of 1 beats

Q2 26

+86.5%

Next: May 5, 2026

Revenue trend · last 8Q

—

—

+67%

+42%

+29%

+23%

+17%

+53%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$2.2B

$2.4B

$2.4B

$3.0B

$2.9B

$3.0B

$2.8B

$4.6B

Margins · last 8Q

Gross

—

Operating

—

Profit

14.6%

View full earnings history →

Wall Street consensus

5 analysts · 40% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

2

40%

Hold

3

60%

Sell

0%

Median Price Target

$20.50

▼ -35.9% vs $31.96

Low $16.00
Median $20.50
High $30.00

Latest: Raymond James · Jun 15, 2026

3 analysts covering

View full analyst page →

vs Industry

How OSCR stacks vs Medical - Healthcare Plans

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.